<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="799">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05150756</url>
  </required_header>
  <id_info>
    <org_study_id>R 35/ 2021</org_study_id>
    <nct_id>NCT05150756</nct_id>
  </id_info>
  <brief_title>Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery</brief_title>
  <official_title>Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative opioid-centric pain management strategies in obese patients are accompanied by&#xD;
      the possible development of; opioid-induced ventilatory impairment (OIVI) and hypoxemia. This&#xD;
      presents as sedation and respiratory depression, combined with upper airway obstruction and&#xD;
      hypercapnia. If it remains undetected and untreated, it can result in increased perioperative&#xD;
      morbidity and mortality.Thus, an increased interest in the use of non-opioid analgesic&#xD;
      adjuncts has been prompted.&#xD;
&#xD;
      Intra-operative intravenous lidocaine infusion has analgesic, anti-inflammatory,&#xD;
      anti-hyperalgesic, opioid-sparing effects with an enhanced recovery after surgery (ERAS)&#xD;
      profile. Its postoperative analgesia may last after reduction of its plasma concentration.&#xD;
      So, lidocaine could be a good alternative in bariatric surgery.&#xD;
&#xD;
      Lidocaine has been studied as part of an opioid-free multimodal analgesia in morbidly obese&#xD;
      patients. Also, its use in bariatric surgery showed a decrease in postoperative opioid use&#xD;
      and improvement in the quality of recovery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      compare the postoperative analgesic effect of intraoperative lidocaine infusion (Study group)&#xD;
      used as a sole analgesic agent, to the intraoperative intravenous morphine (Control group) in&#xD;
      laparoscopic gastric bypass surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain score at rest</measure>
    <time_frame>1hour</time_frame>
    <description>Intensity of pain will be monitored ; on arrival to the PACU, at 20, 40 and 60 minutes after arrival to the PACU by the Numeric Pain Rating Scale. The Numeric Pain Rating Scale (NPRS) is a segmented numeric version of the visual analog scale (VAS) in which the patient selects a whole number (0-10 integers) that best reflects the intensity of pain felt.Where 0 is no pain felt and 10 is the worst pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of surgery</measure>
    <time_frame>3 hours</time_frame>
    <description>measured in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of anesthesia</measure>
    <time_frame>4 hours</time_frame>
    <description>measured in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean values of mean blood pressure (MBP)</measure>
    <time_frame>5 hours</time_frame>
    <description>mean values of MBP will be recorded as base line value, before induction of anesthesia, 5 minutes after endotracheal intubation, before pneumoperitoneum, after release of pneumoperitoneum and 10 min after extubation in the PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients requiring intra-operative morphine</measure>
    <time_frame>4hours</time_frame>
    <description>Number of patients requiring intra-operative morphine will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sPO2</measure>
    <time_frame>5 hours</time_frame>
    <description>recorded in the induction room and in the PACU.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>5 hours</time_frame>
    <description>recorded in the induction room and in the PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative nausea and/or vomiting</measure>
    <time_frame>1 hour</time_frame>
    <description>number of patients will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative sedation score</measure>
    <time_frame>1 hour</time_frame>
    <description>From 0 to 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Aldrete Score</measure>
    <time_frame>1 hour</time_frame>
    <description>score from 0 to 10. Higher score means patient is fit to transfer to the ward. In the PACU, patients with score ≥ 9 will be transferred to the surgical unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean values of heart rate (HR)</measure>
    <time_frame>5 hours</time_frame>
    <description>mean values of HR will be recorded as base line value, before induction of anesthesia, 5 minutes after endotracheal intubation, before pneumoperitoneum, after release of pneumoperitoneum and 10 min after extubation in the PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients requiring postoperative additional morphine doses</measure>
    <time_frame>1 hour</time_frame>
    <description>Number of patients requiring postoperative additional morphine doses willbe recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the total dose of morphine given to each patient</measure>
    <time_frame>5 hours</time_frame>
    <description>the total dose of morphine given to each patient will be recorded in milligrams</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At induction of anesthesia, patients will receive a loading dose of intravenous (IV) 1.5mg/kg lidocaine hydrochloride 2% slowly over 3 min followed by IV infusion of 2mg/kg/hr lidocaine hydrochloride 2% via infusion pump. The infusion will be continued till the end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At induction of anesthesia, patients will receive a loading dose of IV 0.1mg/kg morphine sulphate slowly over 3 minutes followed by IV infusion of normal saline via infusion pump. The infusion will be continued till the end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Hydrochloride 2% Intravenous Solution [XYLOCAINE]</intervention_name>
    <description>At induction of anesthesia, patients will receive a loading dose of 1.5mg/kg lidocaine hydrochloride 2% slowly over 3 min followed by IV infusion of 2mg/kg/hr lidocaine hydrochloride 2% till the end of surgery</description>
    <arm_group_label>Group Lidocaine</arm_group_label>
    <other_name>Xylocaine 2%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine sulphate (10mg/ ml ampoule)</intervention_name>
    <description>At induction of anesthesia, patients will receive a loading dose of IV 0.1mg/kg morphine sulphate slowly over 3 minutes followed by IV infusion of normal saline via infusion pump. The infusion will be continued till the end of surgery</description>
    <arm_group_label>Group Morphine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA physical status I- II&#xD;
&#xD;
          -  body mass index (BMI) ˃ 35&#xD;
&#xD;
          -  scheduled to undergo laparoscopic gastric bypass&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients' refusal&#xD;
&#xD;
          -  hypersensitivity to the study medications&#xD;
&#xD;
          -  patients with known history of; hepatic disease, renal dysfunction&#xD;
&#xD;
          -  severe renal impairment (eGFR &lt;30ml/min/1.73m2)&#xD;
&#xD;
          -  heart failure; left ventricular ejection fraction than 35%&#xD;
&#xD;
          -  any cardiac dysrhythmias; Adam-Stokes syndrome; Wolff- Parkinson-White syndrome,&#xD;
             atrio-ventricular block with heart rate below 50 bpm&#xD;
&#xD;
          -  chronic pain&#xD;
&#xD;
          -  concomitantly taking beta blocking drugs •substance abuse disorder&#xD;
&#xD;
          -  chronic opioid use.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>October 8, 2021</study_first_submitted>
  <study_first_submitted_qc>December 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>December 8, 2021</last_update_submitted>
  <last_update_submitted_qc>December 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ghada M.Samir</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesia, Intensive care and Pain Management</investigator_title>
  </responsible_party>
  <keyword>lidocaine</keyword>
  <keyword>morphine</keyword>
  <keyword>analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

